SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: BigDaddyMac who wrote (635)6/15/1998 12:50:00 AM
From: Profiteer  Respond to of 5402
 
Mr. Vince: I believe the FDA has announced their efforts to speed up approval of life saving products just a few months ago.



To: BigDaddyMac who wrote (635)6/15/1998 1:01:00 AM
From: Prospector  Respond to of 5402
 
Mr Vince

Maybe that's why this stock is less than $5 .. and not $300 there are risks.. Where's your adventure..hehehehe

Prospector ( but it might be closer than ya think)



To: BigDaddyMac who wrote (635)6/15/1998 1:08:00 AM
From: Profiteer  Respond to of 5402
 
Gentlemen, please continue your discussion without me. I really must get some sleep, it's been a long day. I will try and join you tomorrow. Thank you again!



To: BigDaddyMac who wrote (635)6/15/1998 1:28:00 AM
From: justaninvestor  Respond to of 5402
 
Hi Mitch - appreciate your input. I can't speak for the rest of the posters, but I certainly realize that income for SGNC is not right around the corner. But I guess that I'm willing to bet that there could be pent-up enthusiasm for SGNC as the company proceeds with its game plan over the next few months. And why shouldn't there be? Maybe it is a long shot, but if it works, what a tremendous advancement in the world of medicine.

bbruin "HLBS&DW"



To: BigDaddyMac who wrote (635)6/15/1998 7:58:00 AM
From: Benchman  Respond to of 5402
 
It may take 6 years for this product to be approved, but, who says that Sanguine will be the company that get's the approval. I think it is more likely that Sanguine will be bought out by Baxter or somebody, way before then. That being the case, investor's will see a rise in stock price soon, not a decline. The buyout scenario is what attracted me to this stock.

Just my opinion,

Rob.